A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors (CTX-712-CL-01 study): Efficacy and safety in solid tumor cohorts

rogocekib (CTX-712) - Chordia Therap

https://www.abstractsonline.com/pp8/#!/20272/presentation/11453

N. Yamamoto 1; T. Koyama 1; Y. Katsuya 1; J. Sato 1; T. Shimizu 2; Y. Tanoue 3; M. Yamamoto 3; H. Tozaki 3; E. Takahara 3; S. Shoji 3; A. Mizutani 3; D. Morishita 3; R. W. Oda 3; H. Miyake 3; K. Yonemori1

Mar 6, 2024